Real-time enrollment status for this cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 1:59 AM UTC
| NCT Number | NCT06244771 |
| Recruiting Status | Recruiting |
| Condition | Cancer |
| Phase | PHASE1 |
| Target Enrollment | 403 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Frontier Medicines Corporation |
| Last Updated on CT.gov | March 18, 2026 (Mar 18, 2026) |
As of August 28, 2026: Clinical trial NCT06244771 is currently recruiting participants. This phase1 study for cancer is actively seeking new participants at 15 locations across the United States. The study is sponsored by Frontier Medicines Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06244771 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06244771 was last updated Mar 18, 2026 (March 18, 2026). HelloStudys verifies this status automatically.